Introduction of a breast cancer care programme including ultra short hospital stay in 4 early adopter centres: framework for an implementation study
Tóm tắt
Whereas ultra-short stay (day care or 24 hour hospitalisation) following breast cancer surgery was introduced in the US and Canada in the 1990s, it is not yet common practice in Europe. This paper describes the design of the MaDO study, which involves the implementation of ultra short stay admission for patients after breast cancer surgery, and evaluates whether the targets of the implementation strategy are reached. The ultra short stay programme and the applied implementation strategy will be evaluated from the economic perspective. The MaDO study is a pre-post-controlled multi-centre study, that is performed in four hospitals in the Netherlands. It includes a pre and post measuring period of six months each with six months of implementation in between in at least 40 patients per hospital per measurement period. Primary outcome measure is the percentage of patients treated in ultra short stay. Secondary endpoints are the percentage of patients treated according to protocol, degree of involvement of home care nursing, quality of care from the patient's perspective, cost-effectiveness of the ultra short stay programme and cost-effectiveness of the implementation strategy. Quality of care will be measured by the QUOTE-breast cancer instrument, cost-effectiveness of the ultra short stay programme will be measured by means of the EuroQol (administered at four time-points) and a cost book for patients. Cost-effectiveness analysis will be performed from a societal perspective. Cost-effectiveness of the implementation strategy will be measured by determination of the costs of implementation activities. This study will reveal barriers and facilitators for implementation of the ultra short stay programme. Moreover, the results of the study will provide information about the cost-effectiveness of the ultra short stay programme and the implementation strategy. Current Controlled Trials ISRCTN77253391.
Tài liệu tham khảo
Blamey RW, Cataliotti L: EUSOMA accreditation of breast units. Eur J Cancer. 2006, 42 (10): 1331-1337. 10.1016/j.ejca.2006.04.003.
Baum M, Cassileth BR, Daniel R, Ernst E, Filshie J, Nagel GA, Horneber M, Kohn M, Lejeune S, Maher J, Terje R, Smith WB: The role of complementary and alternative medicine in the management of early breast cancer: recommendations of the European Society of Mastology (EUSOMA). Eur J Cancer. 2006, 42 (12): 1711-1714. 10.1016/j.ejca.2006.02.019.
Blamey RW: Guidelines on endocrine therapy of breast cancer EUSOMA. Eur J Cancer. 2002, 38 (5): 615-634. 10.1016/S0959-8049(02)00011-4.
Perry NM: Quality assurance in the diagnosis of breast disease. EUSOMA Working Party. Eur J Cancer. 2001, 37 (2): 159-172. 10.1016/S0959-8049(00)00337-3.
Rutgers EJ: Quality control in the locoregional treatment of breast cancer. Eur J Cancer. 2001, 37 (4): 447-453. 10.1016/S0959-8049(00)00386-5.
Bartelink H, Garavaglia G, Johansson KA, Mijnheer BJ, Van den Bogaert W, van Tienhoven G, Yarnold J: Quality assurance in conservative treatment of early breast cancer. Report on a consensus meeting of the EORTC Radiotherapy and Breast Cancer Cooperative Groups and the EUSOMA (European Society of Mastology). Radiother Oncol. 1991, 22 (4): 323-326. 10.1016/0167-8140(91)90172-D.
Ray-Coquard I, Philip T, de Laroche G, Froger X, Suchaud JP, Voloch A, Mathieu-Daude H, Lurkin A, Farsi F, Bertrand P, Chauvin F: Persistence of medical change at implementation of clinical guidelines on medical practice: a controlled study in a cancer network. J Clin Oncol. 2005, 23 (19): 4414-4423. 10.1200/JCO.2005.01.040.
Ottevanger PB, De Mulder PH, Grol RP, van Lier H, Beex LV: Adherence to the guidelines of the CCCE in the treatment of node-positive breast cancer patients. Eur J Cancer. 2004, 40 (2): 198-204. 10.1016/S0959-8049(03)00660-9.
Mason J, Freemantle N, Nazareth I, Eccles M, Haines A, Drummond M: When is it cost-effective to change the behavior of health professionals?. Jama. 2001, 286 (23): 2988-2992. 10.1001/jama.286.23.2988.
Will BP, Berthelot JM, Le Petit C, Tomiak EM, Verma S, Evans WK: Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer. 2000, 36 (6): 724-735. 10.1016/S0959-8049(99)00340-8.
Dooley WC: Ambulatory mastectomy. Am J Surg. 2002, 184 (6): 545-8; discussion 548-9. 10.1016/S0002-9610(02)01051-6.
Margolese RG, Lasry JC: Ambulatory surgery for breast cancer patients. Ann Surg Oncol. 2000, 7 (3): 181-187. 10.1007/BF02523651.
Warren JL, Riley GF, Potosky AL, Klabunde CN, Richter E, Ballard-Barbash R: Trends and outcomes of outpatient mastectomy in elderly women. J Natl Cancer Inst. 1998, 90 (11): 833-840. 10.1093/jnci/90.11.833.
McManus SA, Topp DA, Hopkins C: Advantages of outpatient breast surgery. Am Surg. 1994, 60 (12): 967-970.
Goodman AA, Mendez AL: Definitive surgery for breast cancer performed on an outpatient basis. Arch Surg. 1993, 128 (10): 1149-1152.
Purushotham AD, McLatchie E, Young D, George WD, Stallard S, Doughty J, Brown DC, Farish C, Walker A, Millar K, Murray G: Randomized clinical trial of no wound drains and early discharge in the treatment of women with breast cancer. Br J Surg. 2002, 89 (3): 286-292. 10.1046/j.0007-1323.2001.02031.x.
Bundred N, Maguire P, Reynolds J, Grimshaw J, Morris J, Thomson L, Barr L, Baildam A: Randomised controlled trial of effects of early discharge after surgery for breast cancer. Bmj. 1998, 317 (7168): 1275-1279.
Bonnema J, van Wersch AM, van Geel AN, Pruyn JF, Schmitz PI, Uyl-de Groot CA, Wiggers T: Cost of care in a randomised trial of early hospital discharge after surgery for breast cancer. Eur J Cancer. 1998, 34 (13): 2015-2020. 10.1016/S0959-8049(98)00258-5.
Rutgers EJ, Nortier JW, Tuut MK, van Tienhoven G, Struikmans H, Bontenbal M, von Meyenfeldt MF, Vreugdenhil G, Benraadt T, Garssen B, Peterse JL: Dutch Institute for Healthcare Improvement guideline, "Treatment of breast cancer" (in Dutch). Ned Tijdschr Geneeskd. 2002, 146 (45): 2144-2151.
Grol R: Personal paper. Beliefs and evidence in changing clinical practice. Bmj. 1997, 315 (7105): 418-421.
Rogers E: Diffusion of Innovations. 1983, New York , Free Press
Cohen J: A power primer. Psychological Bulletin. 1992, 112 (1): 155-159. 10.1037/0033-2909.112.1.155.
Grol R, Cluzeau FA, Burgers JS: Clinical practice guidelines: towards better quality guidelines and increased international collaboration. Br J Cancer. 2003, 89 Suppl 1: S4-8. 10.1038/sj.bjc.6601077.
de Kok M, Scholte RW, Sixma HJ, van der Weijden T, Spijkers KF, van de Velde CJH, Roukema JA, van der Ent FW, Bell AVRJ, von Meyenfeldt MF: The patient’s perspective of the quality of breast cancer care. The development of an instrument to measure quality of care through focus groups and concept mapping with breast cancer patients. Eur J Cancer. 2007, 43 (8): 1257-1264. 10.1016/j.ejca.2007.03.012.
de Kok M, Sixma HJ, Scholte RW, Spijkers KF, van de Velde CJ, Roukema JA, van der Ent FW, Bell AV, von Meyenfeldt MF: What is important in breast cancer care? The patients’ perspective after surgery. Eur J Surg Oncol. 2006, 32 (1): S78-10.1016/S0748-7983(06)70693-X.
EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990, 16 (3): 199-208. 10.1016/0168-8510(90)90421-9.
Rubin DB, Schenker N: Multiple imputation in health-care databases: an overview and some applications. Stat Med. 1991, 10 (4): 585-598. 10.1002/sim.4780100410.
Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, Rutten FFH: Manual for costing research (in Dutch). 2004, Amstelveen, The Netherlands , Health Care Insurance Board, 172-
Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L: The friction cost method for measuring indirect costs of disease. J Health Econ. 1995, 14 (2): 171-189. 10.1016/0167-6296(94)00044-5.
Severens JL: Value for money of changing healthcare services? Economic evaluation of quality improvement. Qual Saf Health Care. 2003, 12 (5): 366-371. 10.1136/qhc.12.5.366.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/7/117/prepub